145 related articles for article (PubMed ID: 38273224)
1. Application of contrast-enhanced ultrasound in diagnosis and grading of bladder urothelial carcinoma.
Zhang HP; Liang RX; Lin XY; Xue ES; Ye Q; Zhu YF
BMC Med Imaging; 2024 Jan; 24(1):26. PubMed ID: 38273224
[TBL] [Abstract][Full Text] [Related]
2. Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study.
Drudi FM; Cantisani V; Liberatore M; Iori F; Erturk SM; Cristini C; Di Pierro G; D'Ambrosio U; Malpassini F; De Felice C; Di Leo N
Ultraschall Med; 2010 Dec; 31(6):589-95. PubMed ID: 20449795
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Ultrasound Differentiation Between Low- and High- Grade Bladder Urothelial Carcinoma and Correlation With Tumor Microvessel Density.
Guo S; Xu P; Zhou A; Wang G; Chen W; Mei J; Xiao F; Liu J; Zhang C
J Ultrasound Med; 2017 Nov; 36(11):2287-2297. PubMed ID: 28556470
[TBL] [Abstract][Full Text] [Related]
4. Quantitative differentiation of non-invasive bladder urothelial carcinoma and inverted papilloma based on CT urography.
Jin P; Yang L; Liu Y; Huang J; Wang X
BMC Urol; 2024 Mar; 24(1):73. PubMed ID: 38532363
[TBL] [Abstract][Full Text] [Related]
5. The comparison between contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging in diagnosing bladder urothelial carcinoma.
Fu W; Liu D; Xiong Y; Liu C; Liu J; Yi X; Zhao T
Int Urol Nephrol; 2023 May; 55(5):1073-1079. PubMed ID: 36422743
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography.
Macrì F; Di Pietro S; Mangano C; Pugliese M; Mazzullo G; Iannelli NM; Angileri V; Morabito S; De Majo M
BMC Vet Res; 2018 Mar; 14(1):84. PubMed ID: 29530040
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasonography in the diagnosis of upper urinary tract urothelial cell carcinoma: a preliminary study.
Drudi FM; Di Candio G; Di Leo N; Malpassini F; Gnecchi M; Cantisani V; Iori F; Liberatore M
Ultraschall Med; 2013 Feb; 34(1):30-7. PubMed ID: 23165789
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma.
Yang Y; Li J; Yao W; Zou G; Ye X; Mo Q
BMC Urol; 2024 Apr; 24(1):88. PubMed ID: 38627689
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the perfusion of occupying lesions of kidney and bladder with contrast-enhanced ultrasound.
Wang XH; Wang YJ; Lei CG
Clin Imaging; 2011; 35(6):447-51. PubMed ID: 22040789
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced Ultrasound in the Bladder: Critical Features to Differentiate Occupied Lesions.
Liu Q; Gong H; Zhu H; Yuan C; Hu B
Comput Math Methods Med; 2021; 2021():1047948. PubMed ID: 34675991
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Ultrasound Characteristics of Renal Pelvis Urothelial Carcinoma and Its Relationship with Microvessel Density.
Zhang B; Li J; Wu Z; Li C; Sun T; Zhuo N; Liang J; Duan Q; Hu H; Tian J
Ultrasound Med Biol; 2021 Feb; 47(2):236-243. PubMed ID: 33158635
[TBL] [Abstract][Full Text] [Related]
12. Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study.
Li Q; Tang J
Ultraschall Med; 2012 Feb; 33(1):87-8; author reply 88-9. PubMed ID: 21959993
[No Abstract] [Full Text] [Related]
13. Differentiation between high- and low-grade urothelial carcinomas using contrast enhanced ultrasound.
Li Q; Tang J; He E; Li Y; Zhou Y; Wang B
Oncotarget; 2017 Sep; 8(41):70883-70889. PubMed ID: 29050329
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound of small cell carcinoma in urinary bladder: a case report and review of literature.
Zhang M; Niu C; Zhang M; Peng Q; Ouyang M
BMC Cancer; 2017 Nov; 17(1):746. PubMed ID: 29126395
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sonographic features for patients with urinary bladder paraganglioma: a comparison with patients with urothelial carcinoma.
Li Y; Guo A; Tang J; Li Q; Fei X; Zhang Y; Gao J
Ultrasound Med Biol; 2014 Mar; 40(3):478-84. PubMed ID: 24412175
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma.
Feng C; Wang Y; Dan G; Zhong Z; Karaman MM; Li Z; Hu D; Zhou XJ
Eur Radiol; 2022 Feb; 32(2):890-900. PubMed ID: 34342693
[TBL] [Abstract][Full Text] [Related]
17. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
Petros FG; Choi W; Qi Y; Moss T; Li R; Su X; Guo CC; Czerniak B; Dinney C; McConkey DJ; Matin SF
J Urol; 2021 Sep; 206(3):548-557. PubMed ID: 33881933
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
Makboul M; Farghaly S; Abdelkawi IF
Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
[TBL] [Abstract][Full Text] [Related]
19. [Significance of apolipoprotein A1 as biomarker for early diagnosis and classification of bladder urothelial carcinoma].
Li CY; Li HJ; Zhang T; Gao HS; Chang JW; Men XL; Wu J; Li JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Apr; 31(4):266-70. PubMed ID: 23595303
[TBL] [Abstract][Full Text] [Related]
20. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
